Table 1 Clinicopathological characteristics of melanoma cohorts

From: In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA

Characteristic

Discovery cohort, n=113

Validation cohort, n=206

Breslow thickness, mm

 Mean

3.08

3.45

 s.d.

2.25

4.61

Age at diagnosis, years

 Mean

58.24

63.43

 s.d.

14.43

16.80

Sex

 Male

58 (50.5%)

80 (38.8%)

 Female

54 (49.5%)

126 (61.2%)

Stage at diagnosis

 Localized

89 (82.4%)

169 (82%)

 Regional

11 (10.2%)

33 (16%)

 Distant

8 (7.4%)

4 (1.9%)

Ulceration

 Absent

67 (59.3%)

67 (52.3%)

 Present

46 (40.7%)

61 (47.7%)

Microsatellites

 Absent

86 (76.1%)

71 (83.5%)

 Present

27 (23.9%)

14 (16.5%)

Received any therapy

 No

90 (81.1%)

153 (81.4%)

 Yes

21 (18.9%)

35 (18.6%)

Back to article page